-
5 Reasons To Remain Buyers Of eBay
Friday, July 21, 2017 - 11:38am | 368Read More...EBay Inc (NASDAQ: EBAY) reported a relatively in-line earning report, but disappointing guidance and tougher comps sent shares falling nearly 4 percent. However, Citi analyst Mark May does not believe the move was justified as he came “away incrementally positive on shares of eBay.” May...
-
10 Reasons To Own FleetCor During The Second Half Of 2017
Thursday, July 13, 2017 - 10:55am | 491Read More...In a note released Thursday, Citi raised its estimates and price target for the shares of FleetCor Technologies, Inc. (NYSE: FLT), giving 10 reasons to own the stock in the second half of 2017. Analyst Peter Christiansen thinks investors would be drawn back to the fundamental drivers for 2017, as...
-
Strong PC Data For June Is Good For Micron Investors
Tuesday, July 11, 2017 - 9:58am | 337Read More...In what could be good tidings for Micron Technology, Inc. (NASDAQ: MU), Citi said in a note that June notebook ODM shipments rose 17 percent month over month, exceeding expectations. This, according to the firm, comes about as the strength in the PC market continues. Analysts led by...
-
Analyst Fights The Temptation To Sell Kimberly-Clark
Friday, July 7, 2017 - 10:03am | 330Read More...Citi analyst Wendy Nicholson sees a difficult road ahead for Kimberly Clark Corp (NYSE: KMB). While she was tempted to give the company a Sell rating, she ended up staying Neutral with a $134 price target. “It feels to us as if KMB is in a tough spot," Nicholson said in a note. "[T]...
-
4 Reasons Square's Impressive Year Will Continue
Thursday, July 6, 2017 - 11:30am | 468Read More...Square Inc. (NYSE: SQ) — the maker of a point-of-sale app that can be used with Apple Inc. (NASDAQ: AAPL) iPhones and iPads — is a top pick in the payment space, according to Citi. Square’s second-quarter performance is up 70 percent and shares are likely to gain more, analyst...
-
Healthcare Repeal Bad For GlaxoSmithKline, Other HIV Treatment Stocks
Wednesday, July 5, 2017 - 12:17pm | 394Read More...The Congressional Budget Office has said that the Senate version of the Republicans’ Affordable Care Act replacement bill could result in 22 million fewer Americans with health insurance. That dramatic reduction in coverage could have major implications for drug makers offering expensive...
-
Pullback Provides Entry Point In Chemours; Citi Upgrades
Wednesday, July 5, 2017 - 11:57am | 274Read More...Citi analyst P.J. Juvekar sees now as the perfect time to buy Chemours Co (NYSE: CC) stock, as he upgraded his rating to Buy with a $45 price target. “We think the recent pullback offers a good entry point. Our investment thesis is primarily based on: 1) Excellent regulation driven growth for...
-
Citi: Court Ruling Lifts Cloud Over Chicago Bridge & Iron Shares
Wednesday, June 28, 2017 - 1:33pm | 510Read More...A Delaware Supreme Court ruling in favor of Chicago Bridge & Iron Company N.V. (NYSE: CBI) in the company’s multibillion-dollar dispute with Westinghouse “is a significant stabilizing event for CB&I shares,” according to Citi. Westinghouse bought CB&I’s nuclear...
-
Why Some See A 16% Return In Sherwin-Williams Shares In A Year's Time
Friday, June 23, 2017 - 2:23pm | 349Read More...Following Sherwin-Williams Co (NYSE: SHW)'s acquisition of The Valspar Corp, Citi resumed coverage of the former at a Buy, with a $410 price target. The price target represents a 16 percent upside from the $354.75 at which the stock closed on Thursday. Analysts PJ Juvekar and Daniel Jester...
-
Citi Says Expect FDA PDUFA Decision For Portola Pharma Early
Friday, June 23, 2017 - 10:52am | 299Read More...Portola Pharmaceuticals Inc (NASDAQ: PTLA) investors should be marking Friday on their calendars. Citi analyst Yigal Nochomovitz expects the Food and Drug Administration to release its decision on betrixaban on Friday, earlier than expected, as it has become a precedent for the FDA to release...
-
Still A Trump Trade Left In Steel? Citi Upgrades Commercial Metals
Tuesday, June 13, 2017 - 9:36am | 327Read More...As the Section 232 probe continues, Citi analyst, Alexander Hacking, sees a favorable market for long steel products, as he upgraded Commercial Metals Company (NYSE: CMC) to Buy. “We see the greatest upside from potential Section 232 trade action in long steel products and long steel mills....
-
XPO Logistics Is Now Citi's Top Pick In Trucking
Monday, June 12, 2017 - 2:48pm | 352Read More...Shares of XPO Logistics Inc (NYSE: XPO) are not only higher by nearly 40 percent since the start of 2017 and hit a new all-time of $60.57 on Monday. Yet, some among the Street expect further upside. Citi's Christian Wetherbee named the Fortune 500 company as the firm's top pick within the trucking...
-
Upcoming Volatility In Apple Could Create Attractive Entry Point Ahead Of iPhone 8 OLED Launch
Monday, June 12, 2017 - 11:23am | 201Read More...Even with possible iPhone 8 OLED delays, Citi analyst Jim Suva expects demand to exceed supply for the 10th-anniversary smartphone causing him to reiterate his Buy rating and $160 price target on Apple Inc. (NASDAQ: AAPL). Notable Comments “We expect demand to outstrip supply as...
-
Analyst: Our Argument For A Sell Rating On Citigroup No Longer Applies
Friday, June 9, 2017 - 10:32am | 419Read More...Analysts at UBS held a bearish view on Citigroup Inc (NYSE: C)'s stock based on the bank having less leverage to "potential positives" in the U.S. such as lower tax rates, faster growth and higher interest rates — while also having greater exposure to "downside scenarios." However, UBS's Saul...
-
3 Things Led Citi To Downgrade Snap
Friday, June 9, 2017 - 10:20am | 362Read More...Citi analyst Mark May downgraded Snap Inc (NYSE: SNAP) from Buy to Neutral with a $20 price target. 3 Reasons User growth was disappointing in the first quarter, weakening the company’s monetization and profit leveraging potential in the near term. A slower rollout of new platforms has slowed...
















